Inhibition of autophagy enhances the selective anti-cancer activity of tigecycline to overcome drug resistance in the treatment of chronic myeloid leukemia

Abstract

Combining tigecycline use with autophagy inhibition is a promising approach for overcoming drug resistance in CML treatment.